PATHOGENETIC RATIONALE FOR THE NECESSITY OF REINFUSION OF ASCITIC FLUID IN PATIENTS WITH LIVER CIRRHOSIS
Keywords:
ascitic fluid, albumin, liver cirrhosis, lymphatic system.Abstract
Liver cirrhosis is a serious disease, being the 11th most frequent cause of death worldwide, with 50% of patients dying within 5 years. Ascites in cirrhosis develops as a result of various pathogenetic factors: hyperaldosteronism, fluid accumulation in the body, portal hypertension, increased lymph production and impaired outflow, reduced drainage function of the parietal peritoneum, autoimmune dysproteinemia, and disturbance of plasma colloid-oncotic balance. Modern medicine offers several methods for treating ascites, including drug therapy, serial laparocenteses with removal of large volumes of fluid, transjugular intrahepatic portosystemic shunts, implanted drainage devices, as well as acellular and concentrated reinfusion therapy. Each of these approaches has its advantages and limitations, and choosing the optimal treatment strategy often presents a challenging task. This article discusses modern methods of ascites treatment using reinfusion with the Fresenius preparation.
References
Shchekotova A.P. Liver cirrhosis. Perm Medical Journal. 2022; 4:41-53. .( in Russ)
Borisov A. E., Kashchenko V. A.. Liver cirrhosis and portal hypertension - St. Petersburg, .( in Russ)
:112 p.
A.V. Shaposhnikov Ascites: Modern approaches to classification and treatment. Russian journal Gastroenterol, Hepatol, Coloproctol. 2001; 3: 25-29.( in Russ)
Sherlock M., Dooley J. Diseases of the liver and biliary tract. Translated from English. Moscow: GEOTAR, 1999: 144-150.( in Russ)
Klimontov V.V., Bulumbaeva D.M. Lymphatic system and adipose tissue: communications in norm and pathology. Obesity and metabolism. 2021;18(3):336-344. .( in Russ)
Ivashkin V.T. Diseases of the liver and biliary tract. Moscow: OOO Izd dom "M-Vesti". 2005. .( in Russ)
Rodionov E.N., Ushakov A.A., Chernyadyev S.A. Differential diagnostics of chronic lymphovenous insufficiency syndrome. Study. Method. Settlement. Yekaterinburg. 2018.30 p. .( in Russ)
Maevskaya M.V., Zharkova M.S., Zhigalova S.B., Kitsenko E.A., Manukyan G.V., Trukhmanov A.S., Maev I.V., Tikhonov I.N., Deeva T.A. Clinical guidelines of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association for the diagnosis and treatment of liver fibrosis and cirrhosis and their complications. Russian Journal of Gastroenterology, Hepatology, Proctology. 2021;31(6):56–102.https://doi.org/10.22416/1382-4376-2021-31-6-56-102.( in Russ)
Saidova Sh.A., Yakubov A.V., Usmanov R.I. "Comparative assessment of the binding function of serum albumin and ascitic fluid in patients with decompensated liver cirrhosis". Medical journal of Uzbekistan. 2000; 1: 47-53( in Uzb)
Gryzunov Yu.A., Dobretseva G.E. Blood serum albumin in clinical medicine. Moscow; Medicine, 1998.( in Russ)
Karimov H.Ya., Zueva E.B., Rakhimov M.M. Serum albumin. Medical journal of Uzbekistan 1998. 6: 111-122.(in Uzb)
Khikmatullaev S.N., Pak N.P., Fainberg I.F. Treatment of severe forms of hepatitis by hemofiltration methods. In: Proceedings of the International Conference on Gastroenterology 2004. .(in Uzb)
